These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
605 related articles for article (PubMed ID: 24945681)
21. Well or poorly differentiated nonfunctioning neuroendocrine carcinoma of the pancreas: a single institution experience with 17 cases. Sellner F; Sobhian B; De Santis M; Pont J; Staettner S; Sellner S; Karner J; Klimpfinger M Eur J Surg Oncol; 2008 Feb; 34(2):191-5. PubMed ID: 17475440 [TBL] [Abstract][Full Text] [Related]
22. Prognostic factors in 151 patients with surgically resected non-functioning pancreatic neuroendocrine tumours. Song KB; Kim SC; Kim JH; Hong SM; Park KM; Hwang DW; Lee JH; Lee YJ ANZ J Surg; 2016 Jul; 86(7-8):563-7. PubMed ID: 25040037 [TBL] [Abstract][Full Text] [Related]
23. TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study. Rindi G; Falconi M; Klersy C; Albarello L; Boninsegna L; Buchler MW; Capella C; Caplin M; Couvelard A; Doglioni C; Delle Fave G; Fischer L; Fusai G; de Herder WW; Jann H; Komminoth P; de Krijger RR; La Rosa S; Luong TV; Pape U; Perren A; Ruszniewski P; Scarpa A; Schmitt A; Solcia E; Wiedenmann B J Natl Cancer Inst; 2012 May; 104(10):764-77. PubMed ID: 22525418 [TBL] [Abstract][Full Text] [Related]
24. Follow-up after curative surgery for pancreatic ductal adenocarcinoma: asymptomatic recurrence is associated with improved survival. Nordby T; Hugenschmidt H; Fagerland MW; Ikdahl T; Buanes T; Labori KJ Eur J Surg Oncol; 2013 Jun; 39(6):559-66. PubMed ID: 23498362 [TBL] [Abstract][Full Text] [Related]
26. Prognostic Validity of the American Joint Committee on Cancer and the European Neuroendocrine Tumors Staging Classifications for Pancreatic Neuroendocrine Tumors: A Retrospective Nationwide Multicenter Study in South Korea. Cho JH; Ryu JK; Song SY; Hwang JH; Lee DK; Woo SM; Joo YE; Jeong S; Lee SO; Park BK; Cheon YK; Han J; Kim TN; Lee JK; Moon SH; Kim H; Park ET; Hwang JC; Kim TH; Jeon TJ; Cho CM; Choi HS; Lee WJ Pancreas; 2016 Aug; 45(7):941-6. PubMed ID: 26765964 [TBL] [Abstract][Full Text] [Related]
27. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors. Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744 [TBL] [Abstract][Full Text] [Related]
28. Analysis of diagnosis and treatment for pancreatic neuroendocrine neoplasms: results of 47 cases in a single institution. Lin XS; Zhu CL; Liu CH; Xie F; Zhou HC; Huang Q Hepatogastroenterology; 2014; 61(136):2383-6. PubMed ID: 25699387 [TBL] [Abstract][Full Text] [Related]
29. [Clinicopathological features of colorectal neuroendocrine neoplasms and prognostic significance of WHO staging system]. Zhang XH; Lu XL; Wu N; Liu B; Wang FY; Zhang RS; Zhou XJ Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):191-6. PubMed ID: 23769440 [TBL] [Abstract][Full Text] [Related]
30. Surgical management of advanced pancreatic neuroendocrine tumors: short-term and long-term results from an international multi-institutional study. Birnbaum DJ; Turrini O; Vigano L; Russolillo N; Autret A; Moutardier V; Capussotti L; Le Treut YP; Delpero JR; Hardwigsen J Ann Surg Oncol; 2015 Mar; 22(3):1000-7. PubMed ID: 25190116 [TBL] [Abstract][Full Text] [Related]
31. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature. Iwasaki T; Nara S; Kishi Y; Esaki M; Shimada K; Hiraoka N Langenbecks Arch Surg; 2017 Sep; 402(6):925-933. PubMed ID: 27915372 [TBL] [Abstract][Full Text] [Related]
32. Tumor staging but not grading is associated with adverse clinical outcome in neuroendocrine tumors of the appendix: a retrospective clinical pathologic analysis of 138 cases. Volante M; Daniele L; Asioli S; Cassoni P; Comino A; Coverlizza S; De Giuli P; Fava C; Manini C; Berruti A; Papotti M Am J Surg Pathol; 2013 Apr; 37(4):606-12. PubMed ID: 23426123 [TBL] [Abstract][Full Text] [Related]
33. Outcomes of resected nonfunctional pancreatic neuroendocrine tumors: Do size and symptoms matter? Sallinen V; Haglund C; Seppänen H Surgery; 2015 Dec; 158(6):1556-63. PubMed ID: 26070847 [TBL] [Abstract][Full Text] [Related]
34. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection]. Ridwelski K; Meyer F; Schmidt U; Lippert H Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961 [TBL] [Abstract][Full Text] [Related]
35. Histologic characterization and improved prognostic evaluation of 209 gastric neuroendocrine neoplasms. La Rosa S; Inzani F; Vanoli A; Klersy C; Dainese L; Rindi G; Capella C; Bordi C; Solcia E Hum Pathol; 2011 Oct; 42(10):1373-84. PubMed ID: 21531442 [TBL] [Abstract][Full Text] [Related]
36. Surgery and staging of pancreatic neuroendocrine tumors: a 14-year experience. Ito H; Abramson M; Ito K; Swanson E; Cho N; Ruan DT; Swanson RS; Whang EE J Gastrointest Surg; 2010 May; 14(5):891-8. PubMed ID: 20224984 [TBL] [Abstract][Full Text] [Related]
37. Neuroendocrine tumors of colon and rectum: validation of clinical and prognostic values of the World Health Organization 2010 grading classifications and European Neuroendocrine Tumor Society staging systems. Shen C; Yin Y; Chen H; Tang S; Yin X; Zhou Z; Zhang B; Chen Z Oncotarget; 2017 Mar; 8(13):22123-22134. PubMed ID: 27902460 [TBL] [Abstract][Full Text] [Related]
38. Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study. Larghi A; Capurso G; Carnuccio A; Ricci R; Alfieri S; Galasso D; Lugli F; Bianchi A; Panzuto F; De Marinis L; Falconi M; Delle Fave G; Doglietto GB; Costamagna G; Rindi G Gastrointest Endosc; 2012 Sep; 76(3):570-7. PubMed ID: 22898415 [TBL] [Abstract][Full Text] [Related]
39. Survival prognostic factors of gastro-enteric-pancreatic neuroendocrine tumors after primary tumor resection in a single tertiary center: Comparison of gastro-enteric and pancreatic locations. Russolillo N; Vigano' L; Razzore P; Langella S; Motta M; Bertuzzo F; Papotti M; Ferrero A Eur J Surg Oncol; 2015 Jun; 41(6):751-7. PubMed ID: 25887286 [TBL] [Abstract][Full Text] [Related]
40. Re-evaluation of cases with gastroenteropancreatic neuroendocrine tumors between 2004 and 2012 according to the 2010 criteria. Ozkara S; Aker F; Yesil A; Senates E; Canbey C; Yitik A; Gonen C Hepatogastroenterology; 2013 Oct; 60(127):1665-72. PubMed ID: 24627925 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]